Daily news email for August 25, 2010 | Click here for updated news
SourceSolution News
New reporting features added to the Supplier Relationship Management system. Sign up here for our daily webinar to learn more.
Search over 86,000 clinical trials by phase of development and indication at www.sourcesolution.com
PlanIt client portal software lets you exchange and track documents, manage budgets and assign tasks. 3 day implementation!
|
BioSpace
Somaxon Pharmaceuticals, Inc., Procter & Gamble To Launch Insomnia Drug In Sept,, Will Co-Promote Silenor With a Combined 215 Sales Reps in the U.S. Market, Stock Rises 53.12% at11:06AM EDT
Inspire Pharmaceuticals, Inc. Stops Prolacria Development Program, Amends Agreement with Allergan Inc.
University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen BioSciences, Inc.'s Homspera(R)
Emisphere Technologies, Inc. Announces Agreements to Raise $7 Million in Private Placement Transactions
Genetic Variations Associated With Development of ESRD in Chinese Patients with Diabetes, Study
|
BioSpace - Breaking News
Celgene Corporation Expects to Receive a Paragraph IV Notification of an ANDA Filing for REVLIMID(R)
PolyTherics' Growth Spurs Move to Larger Premises
Hemispherx Biopharma Settles All Securities Class Actions
Biodel Inc. to Raise $9.4 Million Through Registered Direct Offering
Data on VIVUS, Inc.'s Qnexa(R) to Be Presented at the Congress
|
New York Times- Pharmaceuticals
Lilly Stops Alzheimer's Drug Trials
AARPSays Brand-Name Drug Prices Up 8% in 2009
AARP Says Brand-Name Drug Prices Up 8% in 2009
What to Tell Alzheimer’s Patients After a Trial Goes Awry
A Problem Easily Fixed
|
OnBioVC
Gemin X Pharmaceuticals, Inc.: Series E $8M
Great Lakes Pharmaceuticals, Inc.: Series B $3.1M
Health Market Science, Inc.: Series B $6.1M
Solazyme, Inc.: Series D $52M
CeNeRx BioPharma, Inc.: Series C $10M
|
Outsourcing-Pharma
Asia Pacific trial sector poised for continued growth, says Novotech
ERT develops IVR suicidality monitoring for trials
Demand for discovery services recovering, says Domainex
Biomarkers indispensible in cancer drug development, says Quintiles
Data, patients and payers key to New Health success, says Quintiles
|
